Fly Intel: Top five weekend stock stories
Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Catalent (CTLT) has agreed to buy closely held Paragon Bioservices for $1.2B, The Wall Street Journal's Jared Hopkins and Cara Lombardo reported, citing people familiar with the matter. The all-cash deal, which is expected to be announced Monday morning, would help Catalent expand its gene-therapy manufacturing capabilities, sources said. The transaction is expected to close in the second quarter, the publication added. 2. Volkswagen (VWAGY) plans to build a fully electric sports utility vehicle for China from 2021, taking on the Chinese market leader Tesla's (TSLA) Model X as the German carmaker ramps up production of zero emissions vehicles, Reuters' Edward Taylor reported. 3. CVS (CVS) should discuss its expansion plans for HealthHub at a June investor date, and while the stock has tumbled on stalled earnings growth and concerns that margins as a drug-price negotiator will fall, CVS' assets leave it "uniquely well positioned" for a future when consumers gain more control over healthcare and prices fall, Jack Hough wrote in this week's edition of Barron's. It might be time to buy the shares, Hough contended. 4. AT&T (T) subsidiary Warner Bros' "Shazam!" easily stayed number 1 in its second weekend, earning another $25.1M from 4,306 locations. The movie's 10-day domestic tally stands at $94.9M. Overseas, "Shazam!" also topped the chart with $35.9M for $258.8M globally. The pic sports an A CinemaScore and a 91% Rotten Tomatoes score. 5. Alcon (ALC), Huntington Bancshares (HBAN), KeyCorp (KEY), Valero Energy (VLO), PepsiCo (PEP), Medtronic (MDT), Pinterest (PINS), and Disney (DIS) saw positive mentions in Barron's.